Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-12 · accession 0001193125-25-280500 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-13 | 2025-11-12 | GMED | Davidar David D | Dir | M - OptEx | $25.52 | +25.0K | 541.3K | +5% | +$638.0K |
| D | 2025-11-13 | 2025-11-12 | GMED | Davidar David D | Dir | S - Sale+OE | $86.00 | -25.0K | 516.3K | -5% | -$2.15M |
| D | 2025-11-13 | 2025-11-12 | GMED | Davidar David D | Dir | M - OptEx | $0.00 | -25.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-11-12 | M | A | 25,000 | $25.52 | 541,275 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-11-12 | S | D | 25,000 | $86.00 | 516,275 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at a price range of $86.00 - $86.01, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4. |
| 3 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2025-11-12 | M | D | 25,000 | $0.00 | 0 | D | $25.52 · — to 2026-01-25 | 25,000 Class A Common Stock | (F3) These options were granted on January 25, 2016 and are fully vested. |